Buy or sell Avadim Technologies stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Avadim Technologies Stock

Avadim Technologies Inc is a life sciences company.

About Avadim Technologies Stock

Avadim Technologies Inc is a life sciences company that has developed a new class of life sciences solutions based on Pathogenesis Based Therapies (“PBTs”) which work to optimize the stratum corneum, integumentary functions and the associated reactive tissue. Their platform of therapies works to protect and support natural physiological functions of the outer barrier of the body, to super normalize it, supporting treatments within their three series of therapies for infection prevention, neuromuscular disorders and barrier repair. Their platform and technologies use a targeted topical delivery system, are non-toxic and are effective without the side effects of other remedy approaches. Initial acceptance in the U.S. clinical market of their first PBTs and their novel preventative approach, have shown both cost avoidance and superior effectiveness in addressing specific needs in healthcare. Avadim’s advanced therapeutic class of Pathogenesis Based Therapies is capable of unlocking pathways to address emerging gaps in global health.

Funding History

December 2014$350K
July 2015$2.3M
September 2016$917K
December 2016$580K

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Avadim Technologies or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo